C
Claritas Pharmaceuticals Inc
XTSX:CLAS
Claritas Pharmaceuticals Inc
XTSX:CLAS
Price:
0.295
CAD
Market Closed
Market Cap:
CA$10.4m
Income Statement
Earnings Waterfall
Claritas Pharmaceuticals Inc
Claritas Pharmaceuticals Inc
Income Statement
Claritas Pharmaceuticals Inc
Claritas Pharmaceuticals Inc
Currency: USD
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | ||
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||
| Operating Expenses |
2
|
3
|
13
|
0
|
0
|
0
|
|
| Selling, General & Administrative |
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Research & Development |
0
|
0
|
2
|
0
|
0
|
0
|
|
| Other Operating Expenses |
5
|
5
|
12
|
2
|
2
|
2
|
|
| Operating Income |
2
N/A
|
3
+9%
|
13
+381%
|
0
-97%
|
0
-49%
|
0
+166%
|
|
| Pre-Tax Income | |||||||
| Interest Income Expense |
2
|
2
|
3
|
0
|
0
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Pre-Tax Income |
4
N/A
|
5
+12%
|
13
+167%
|
(1)
N/A
|
(2)
-33%
|
(2)
+6%
|
|
| Net Income | |||||||
| Tax Provision |
(1)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
4
|
5
|
13
|
(2)
|
(2)
|
(2)
|
|
| Net Income (Common) |
(4)
N/A
|
(4)
+13%
|
4
N/A
|
(12)
N/A
|
(5)
+56%
|
(5)
+11%
|
|
| EPS (Diluted) |
-0.16
N/A
|
-0.13
+19%
|
0.15
N/A
|
-0.38
N/A
|
-0.16
+58%
|
-0.13
+19%
|
|
Switch to:
Switch to:
See Also
Discover More
